NCT04748536View on ClinicalTrials.gov

Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

April 5, 2021

Study Completion Date

April 5, 2021

Conditions
Healthy Volunteer
Interventions
DRUG

IRL201104

lyophilised powder for reconstitution for IV dosing

DRUG

Placebo

Matching placebo for IRL201104

Trial Locations (1)

Unknown

Hammersmith Medicines Research, London

Sponsors
All Listed Sponsors
lead

Revolo Biotherapeutics

INDUSTRY

NCT04748536 - Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers | Biotech Hunter | Biotech Hunter